Comcom, Irene .
HRN: 09-25-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2024
CO-AMOXICLAV 625MG (TAB)
02/24/2024
03/02/2024
PO
625mg
BID X 7 Days
S/P NSVD; PROM X 59 Hours
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes